v3.26.1
Statements of Changes In Shareholders’ Equity (Deficit) - USD ($)
Ordinary Shares
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Total
Balance at Jan. 17, 2024
Balance (in Shares) at Jan. 17, 2024      
Founder Shares issued to Initial Shareholder [1] $ 150 24,850 25,000
Founder Shares issued to Initial Shareholder (in Shares) [1] 1,500,000      
Net income (77,094) (77,094)
Balance at Dec. 31, 2024 $ 150 24,850 (77,094) (52,094)
Balance (in Shares) at Dec. 31, 2024 1,500,000      
Issuance of Private Placement Units net of issuance cost of $9,453 $ 23 2,333,424 2,333,447
Issuance of Private Placement Units net of issuance cost of $9,453 (in Shares) 234,290      
Issuance of Public Rights net of issuance costs of $39,560 1,280,440 1,280,440
Issuance of Representative Shares $ 21 360,979 361,000
Issuance of Representative Shares (in Shares) 210,000      
Issuance of independent director shares 61,478 61,478
Accretion of carrying value to redemption value (4,061,171) (1,028,952) (5,090,123)
Net income 1,285,090 1,285,090
Balance at Dec. 31, 2025 $ 194 $ 179,044 $ 179,238
Balance (in Shares) at Dec. 31, 2025 1,944,290      
[1] Ordinary shares have been retroactively restated to reflect the Sponsor’s forfeiture of 225,000 Founder Shares on March 10, 2025 for no consideration as the underwriters of the IPO did not exercise the over-allotment option.